A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis...
ConjunctivitisTo engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofluorescence (CC-IFA). The polymerase chain reaction (PCR) will be used as a referee for discrepant cases.
Olopatadine Eye Drops and Allergy Skin Testing
Allergic RhinitisAllergic ConjunctivitisUse of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Allergic ConjunctivitisThis study will evaluate the safety and efficacy of a new allergy medication
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis...
ConjunctivitisAllergicThis post-marketing surveillance study will assess the safety and efficacy of Lastacaft® Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic Conjunctivitis as prescribed as standard of care in clinical practice in Korea.
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis...
ConjunctivitisAtopic DermatitisThe primary objective of the study is to characterize the clinical phenotype(s) of DUPIXENT®-associated conjunctivitis events. The secondary objectives of the study are to characterize the course of conjunctivitis events during the observation period and collect and assess data on treatment for conjunctivitis events and its effectiveness.
Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
ConjunctivitisAllergicThis study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Relestat Ophthalmic Solution 0.05% in patients with allergic conjunctivitis who are treated with Relestat as standard of care in clinical practice.
An Optional Investigation of Biomarkers of Efficacy
RhinoconjunctivitisHouse Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. ToleroMune House Dust Mite (TM-HDM) is being developed for the treatment of HDM allergy. Study TH002 evaluated the efficacy, safety and tolerability of TM-HDM. This study will identify cellular, proteomic or genetic biomarkers of efficacy to TM-HDM treatment in TH002 study participants
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate...
Allergic ConjunctivitisTo compare the safety and tolerability of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% combination ophthalmic solution versus its vehicle in healthy adult subjects and in pediatric subjects.
Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis...
AllergySafety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
Allergic ConjunctivitisThe purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.